|
| 36937425 | Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 |
| 38023731 | m<sup>6</sup>A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer. | NAR Cancer | 2023 |
| 37703814 | Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial Outcomes. | Cancer Control | 2023 |
| 37286980 | Correction: Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hiâ¿¿C, Microâ¿¿C, and promoter capture Microâ¿¿C. | Epigenetics Chromatin | 2023 |
| 37087309 | Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314. | Eur Urol Oncol | 2023 |
| 37080171 | Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study. | Oncology | 2023 |
| 37069142 | Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer. | Nat Commun | 2023 |
| 36872133 | Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. | Eur Urol | 2023 |
| 36937425 | Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 |
| 37104368 | Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma. | PLoS One | 2023 |
| 38023731 | m<sup>6</sup>A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer. | NAR Cancer | 2023 |
| 37703814 | Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial Outcomes. | Cancer Control | 2023 |
| 37087309 | Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314. | Eur Urol Oncol | 2023 |
| 37286980 | Correction: Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hiâ¿¿C, Microâ¿¿C, and promoter capture Microâ¿¿C. | Epigenetics Chromatin | 2023 |
| 37080171 | Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study. | Oncology | 2023 |
| 37104368 | Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma. | PLoS One | 2023 |
| 37069142 | Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer. | Nat Commun | 2023 |
| 36872133 | Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. | Eur Urol | 2023 |
| 34785776 | MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis. | Oncogene | 2022 |
| 35769412 | Epigenetic dysregulation in meningiomas. | Neurooncol Adv | 2022 |
| 36291764 | Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells. | Cancers (Basel) | 2022 |
| 36090617 | Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma. | Eur J Radiol Open | 2022 |
| 35437583 | Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35406487 | FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. | Cancers (Basel) | 2022 |
| 36544209 | Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hi-C, Micro-C, and promoter capture Micro-C. | Epigenetics Chromatin | 2022 |
| 34785776 | MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis. | Oncogene | 2022 |
| 34757449 | CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. | Eur Radiol | 2022 |
| 35769412 | Epigenetic dysregulation in meningiomas. | Neurooncol Adv | 2022 |
| 35406487 | FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer. | Cancers (Basel) | 2022 |
| 35437583 | Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 36544209 | Characterizing chromatin interactions of regulatory elements and nucleosome positions, using Hi-C, Micro-C, and promoter capture Micro-C. | Epigenetics Chromatin | 2022 |
| 36090617 | Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma. | Eur J Radiol Open | 2022 |
| 36291764 | Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells. | Cancers (Basel) | 2022 |
| 34757449 | CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. | Eur Radiol | 2022 |
| 34312968 | VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer. | Mol Oncol | 2021 |
| 33741028 | Molecular and computational approaches to map regulatory elements in 3D chromatin structure. | Epigenetics Chromatin | 2021 |
| 33713608 | Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. | Am J Hum Genet | 2021 |
| 34312968 | VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer. | Mol Oncol | 2021 |
| 34604815 | Genetic discovery and risk characterization in type 2 diabetes across diverse populations. | HGG Adv | 2021 |
| 33741028 | Molecular and computational approaches to map regulatory elements in 3D chromatin structure. | Epigenetics Chromatin | 2021 |
| 33713608 | Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. | Am J Hum Genet | 2021 |
| 34604815 | Genetic discovery and risk characterization in type 2 diabetes across diverse populations. | HGG Adv | 2021 |
| 32270030 | Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells. | Sci Adv | 2020 |
| 32017074 | Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype. | Int J Cancer | 2020 |
| 32109873 | Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma. | J Neurosurg | 2020 |
| 32270030 | Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells. | Sci Adv | 2020 |
| 32925947 | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. | PLoS Genet | 2020 |
| 32017074 | Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype. | Int J Cancer | 2020 |
| 32925947 | TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma. | PLoS Genet | 2020 |
| 32109873 | Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma. | J Neurosurg | 2020 |